Topical Roflumilast Approved for Psoriasis in Adults and Adolescents

New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition

Dramatic Improvement in Generalized Pustular Psoriasis With IL-36 Inhibitor

Tapinarof shows ‘robust efficacy’ in phase 3 trials

Mount Sinai Health System Names New Chair of Dermatology and Announces Dean for Clinical Therapeutics

Mount Sinai Researcher Identifies Single Gene Biomarker to Differentiate Between Atopic Dermatitis and Psoriasis Using Adhesive Tape Strips

"Roflumilast Cream Superior to Vehicle in Treatment of Plaque Psoriasis"

"Arcutis’ Roflumilast Cream Could Be “Game Changer” for Plaque Psoriasis"

"Psoriasis Cream Succeeds in Early Trial" - Kristen Monaco

Mount Sinai Researchers Discover That Topical Treatment Improves Chronic Plaque Psoriasis

Tape Strips Identified as Non-Invasive Approach to Assess Skin Biomarkers in Children With Atopic Dermatitis